{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:30:33Z","timestamp":1793136633851,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":296,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL148182"],"award-info":[{"award-number":["R01HL148182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL127153"],"award-info":[{"award-number":["R01HL127153"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL169695"],"award-info":[{"award-number":["R01HL169695"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-CX001901"],"award-info":[{"award-number":["I01-CX001901"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","award":["UCLA-2024-MR-42\\u201301-Christodoulou_CLMA179688"],"award-info":[{"award-number":["UCLA-2024-MR-42\\u201301-Christodoulou_CLMA179688"]}],"id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","award":["UCLA-2024-MR-44\\u201301-Zhong_CLMA178381"],"award-info":[{"award-number":["UCLA-2024-MR-44\\u201301-Zhong_CLMA178381"]}],"id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","award":["4\\u2013401480-XZ-62259-EXSTR"],"award-info":[{"award-number":["4\\u2013401480-XZ-62259-EXSTR"]}],"id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["I01-CX002208"],"award-info":[{"award-number":["I01-CX002208"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["R01HL159803"],"award-info":[{"award-number":["R01HL159803"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["R01HL159200"],"award-info":[{"award-number":["R01HL159200"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.jocmr.2025.101980","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:33:24Z","timestamp":1761593604000},"page":"101980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ferumoxytol-enhanced cardiovascular magnetic resonance imaging: applications and technical advances"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8854-2976","authenticated-orcid":false,"given":"Kim-Lien","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Hin","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Bedayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Jung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocmr.2025.101980_bib1","first-page":"157","article-title":"First use of GdDTPA\/dimeglumine in man","volume":"16","author":"Laniado","year":"1984","journal-title":"Physiol Chem Phys Med NMR"},{"key":"10.1016\/j.jocmr.2025.101980_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/radiol.2020202903","article-title":"Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation","volume":"298","author":"Weinreb","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib3","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1007\/s00330-019-06171-2","article-title":"Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients","volume":"29","author":"Uhlig","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib4","first-page":"223","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group ii gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jocmr.2025.101980_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1148\/radiol.2018181151","article-title":"Gadolinium retention: a research roadmap from the 2018 NIH\/ACR\/RSNA workshop on gadolinium chelates","author":"McDonald","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00330-023-10281-3","article-title":"Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward","volume":"34","author":"Van Der Molen","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib7","article-title":"Update on gadolinium based contrast agent safety, from the AJR special series on contrast media","author":"Starekova","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jocmr.2025.101980_bib8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jmri.21969","article-title":"Biodistribution of gadolinium-based contrast agents, including gadolinium deposition","volume":"30","author":"Aime","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-020-00682-4","article-title":"SCMR position paper (2020) on clinical indications for cardiovascular magnetic resonance","volume":"22","author":"Leiner","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib10","first-page":"137","article-title":"The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies","volume":"16","author":"Carr","year":"1984","journal-title":"Physiol Chem Phys Med NMR"},{"key":"10.1016\/j.jocmr.2025.101980_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmri.1880070132","article-title":"MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent","volume":"7","author":"Anzai","year":"1997","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2008.496","article-title":"Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?","volume":"75","author":"Neuwelt","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocmr.2025.101980_bib13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.crad.2016.03.020","article-title":"Cardiovascular MRI with ferumoxytol","volume":"71","author":"Finn","year":"2016","journal-title":"Clin Radio"},{"key":"10.1016\/j.jocmr.2025.101980_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1148\/radiol.2017162759","article-title":"Ten things you might not know about iron oxide nanoparticles","volume":"284","author":"Daldrup-Link","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jmri.24691","article-title":"Emerging applications for ferumoxytol as a contrast agent in MRI","volume":"41","author":"Bashir","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2214\/ajr.182.5.1821181","article-title":"Blood pool MR angiography of aortic stent-graft endoleak","volume":"182","author":"Ersoy","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jocmr.2025.101980_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jmri.20235","article-title":"First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent","volume":"21","author":"Li","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1148\/radiol.2423052101","article-title":"Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience","volume":"242","author":"Li","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/mrm.25491","article-title":"Four-dimensional, multiphase, steady-state imaging with contrast enhancement (MUSIC) in the heart: a\u00a0feasibility study in children","volume":"74","author":"Han","year":"2015","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jmri.25106","article-title":"Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease","volume":"43","author":"Cheng","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/mrm.26376","article-title":"Self-gated 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) using rotating cartesian K-space (ROCK): validation in children with congenital heart disease","volume":"78","author":"Han","year":"2017","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12968-017-0352-8","article-title":"4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease","volume":"19","author":"Nguyen","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12968-017-0422-y","article-title":"Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging","volume":"19","author":"Nguyen","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2017162899","article-title":"Ferumoxytol-enhanced MR angiography for vascular access mapping before transcatheter aortic valve replacement in patients with renal impairment: a step toward patient-specific care","volume":"286","author":"Nguyen","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcmg.2019.01.024","article-title":"Ferumoxytol-enhanced CMR for vasodilator stress testing: a feasibility study","volume":"12","author":"Nguyen","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/biolre\/ioac168","article-title":"Ferumoxytol dynamic contrast enhanced magnetic resonance imaging identifies altered placental cotyledon perfusion in rhesus macaques","volume":"107","author":"Seiter","year":"2022","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jocmr.2025.101980_bib27","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/jmri.28504","article-title":"Pulmonary MRA during pregnancy: early experience with ferumoxytol","volume":"57","author":"Starekova","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1148\/radiol.12112694","article-title":"USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure","volume":"265","author":"Sigovan","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1148\/radiol.2021203696","article-title":"Four-dimensional multiphase steady-state MRI with ferumoxytol enhancement: early multicenter feasibility in pediatric congenital heart disease","volume":"300","author":"Nguyen","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCIMAGING.123.015404","article-title":"Diagnostic performance and safety of a novel ferumoxytol-enhanced coronary magnetic resonance angiography","volume":"16","author":"Dong","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38222-6","article-title":"Iron oxide nanoparticles as positive T(1) contrast agents for low-field magnetic resonance imaging at 64 mT","volume":"13","author":"Oberdick","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocmr.2025.101980_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.29381","article-title":"Vascular aging in the choroid plexus: a 7T ultrasmall superparamagnetic iron oxide (USPIO)-MRI study","author":"Sun","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib33","unstructured":"Covis. Feraheme Drug Label. \u3008https:\/\/www.feraheme.com\u3009. 2009. Accessed July 1, 2024."},{"key":"10.1016\/j.jocmr.2025.101980_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.kint.2016.12.037","article-title":"Current and potential imaging applications of ferumoxytol for magnetic resonance imaging","volume":"92","author":"Toth","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocmr.2025.101980_bib35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/thno.67375","article-title":"Repurposing ferumoxytol: diagnostic and therapeutic applications of an FDA-approved nanoparticle","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jocmr.2025.101980_bib36","unstructured":"Sandoz. Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia. \u3008https:\/\/www.us.sandoz.com\/news\/media-releases\/sandoz-launches-first-generic-high-dose-intravenous-iron-ferumoxytol-injection\/\u3009. 2021. Accessed July 1, 2024."},{"key":"10.1016\/j.jocmr.2025.101980_bib37","unstructured":"Azurity. Azurity Pharmaceuticals Announces the FDA Approval of Ferabright (ferumoxytol injection), the First and Only Iron-Based Contrast Agent Indicated for Magnetic Resonance Imaging of the Brain. \u3008https:\/\/azurity.com\/azurity-pharmaceuticals-announces-the-fda-approval-of-ferabrighttm-ferumoxytol-injection-the-first-and-only-iron-based-contrast-agent-indicated-for-magnetic-resonance-imaging-of-the-brain\/\u3009. 2025. Accessed October 23, 2025."},{"key":"10.1016\/j.jocmr.2025.101980_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2018-05-815944","article-title":"Iron deficiency","volume":"133","author":"Camaschella","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jocmr.2025.101980_bib39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2362.2009.02130.x","article-title":"Physicochemical properties of ferumoxytol, a new intravenous iron preparation","volume":"39","author":"Balakrishnan","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jocmr.2025.101980_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201906539","article-title":"Iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging: fundamentals, challenges, applications, and prospectives","volume":"33","author":"Jeon","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.jocmr.2025.101980_bib41","unstructured":"ACR Manual on Contrast Media (Version 10.3). \u3008https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Clinical-Resources\/Contrast_Media.pdf\u3009. 2024. Accessed July 1, 2024."},{"key":"10.1016\/j.jocmr.2025.101980_bib42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jcmg.2020.06.038","article-title":"Diagnostic applications of ultrasmall superparamagnetic particles of iron oxide for imaging myocardial and vascular inflammation","volume":"14","author":"Merinopoulos","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s12410-021-09552-8","article-title":"USPIOs as targeted contrast agents in cardiovascular magnetic resonance imaging","volume":"14","author":"Lu","year":"2021","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1016\/j.jocmr.2025.101980_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12968-015-0183-4","article-title":"Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide","volume":"17","author":"Alam","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12975-012-0172-y","article-title":"Ferumoxytol-enhanced MRI to image inflammation within human brain arteriovenous malformations: a pilot investigation","volume":"3","author":"Hasan","year":"2012","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jocmr.2025.101980_bib46","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/ATVBAHA.111.239871","article-title":"Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study","volume":"32","author":"Hasan","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jocmr.2025.101980_bib47","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/heartjnl-2016-311018","article-title":"Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction","volume":"103","author":"Stirrat","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jocmr.2025.101980_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1148\/radiol.2019190489","article-title":"Pharmacokinetics of ferumoxytol in the abdomen and pelvis: a dosing study with 1.5- and 3.0-T MRI relaxometry","volume":"294","author":"Wells","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib49","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jocmr.2025.101980_bib50","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/1358863X17701592","article-title":"2016 AHA \/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary","volume":"22","author":"Gerhard-Herman","year":"2017","journal-title":"Vasc Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib51","first-page":"H567","article-title":"Changes in myocardial blood volume with graded coronary stenosis","volume":"272","author":"Lindner","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib52","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mrm.29026","article-title":"Automatic segmentation of peripheral arteries and veins in ferumoxytol-enhanced MR angiography","volume":"87","author":"Ghodrati","year":"2022","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib53","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/hrt.2003.020875","article-title":"Changes in myocardial blood volume over a wide range of coronary driving pressures: role of capillaries beyond the autoregulatory range","volume":"90","author":"Le","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jocmr.2025.101980_bib54","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jcmg.2009.07.010","article-title":"Myocardial blood volume is associated with myocardial oxygen consumption: an experimental study with cardiac magnetic resonance in a canine model","volume":"2","author":"McCommis","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4518","article-title":"Ferumoxytol-enhanced magnetic resonance T1 reactivity for depiction of myocardial hypoperfusion","volume":"34","author":"Colbert","year":"2021","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jocmr.2025.101980_bib56","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/jmri.27494","article-title":"Estimation of fractional myocardial blood volume and water exchange using ferumoxytol-enhanced magnetic resonance imaging","volume":"53","author":"Colbert","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib57","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mrm.29530","article-title":"Fractional myocardial blood volume by ferumoxytol-enhanced MRI: estimation of ischemic burden","volume":"89","author":"Colbert","year":"2023","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006427","article-title":"Quantitative assessment of coronary microvascular function: dynamic single-photon emission computed tomography, positron emission tomography, ultrasound, computed tomography, and magnetic resonance imaging","volume":"10","author":"Feher","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib59","unstructured":"Li X.M., Pogosyan A., Ming Z., Finn J.P., Nguyen K.L. Fractional Myocardial Blood Volume Estimation using Ferumoxytol-Enhanced Magnetic Resonance Imaging: Early Findings in Healthy Human Subjects. Paper\/Poster presented at: Society of Magnetic Resonance Angiography; 2022; Los Angeles, CA."},{"key":"10.1016\/j.jocmr.2025.101980_bib60","unstructured":"Li X.M., Ming Z., Lee H., Finn J.P., Christodoulou A.G., Nguyen K.L. Quantification of Fractional Myocardial Blood Volume Throughout the Cardiac Cycle using Ferumoxytol-Enhanced Magnetic Resonance Multitasking. Paper\/Poster presented at: Society for Cardiovascular Magnetic Resonance; 2023; San Diego, CA."},{"key":"10.1016\/j.jocmr.2025.101980_bib61","unstructured":"Huang Y.G.X., Zhang X., Malagi A., Yang C., Huang L., Li X., Yoosefian G., Christodoulou A.G., Li D., Han H., Dharmakumar D., Yang H.J. Free-running, Ferumoxytol-Enhanced Cardiac High-Dynamic-Range QSM (HDR-QSM) for Motion-resolved Myocardial Blood Volume Quantification. Paper\/Poster presented at: Scientific Sessions of the ISMRM; 2024; Singapore."},{"key":"10.1016\/j.jocmr.2025.101980_bib62","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1148\/radiology.219.3.r01jn44828","article-title":"Cine MR angiography of the heart with segmented true fast imaging with steady-state precession","volume":"219","author":"Carr","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1148\/radiology.178.2.1987592","article-title":"Cineangiography of the heart in a single breath hold with a segmented turboFLASH sequence","volume":"178","author":"Atkinson","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib64","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jmri.20163","article-title":"On flow effects in balanced steady-state free precession imaging: pictorial description, parameter dependence, and clinical implications","volume":"20","author":"Markl","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib65","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/mrm.20052","article-title":"Analysis of multiple-acquisition SSFP","volume":"51","author":"Bangerter","year":"2004","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.29295","article-title":"Ferumoxytol-enhanced cardiac cine MRI reconstruction using a variable-splitting spatiotemporal network","author":"Gao","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib67","doi-asserted-by":"crossref","first-page":"W565","DOI":"10.2214\/AJR.11.7503","article-title":"Contrast-enhanced MR angiography of cavopulmonary connections in adult patients with congenital heart disease","volume":"199","author":"Wagner","year":"2012","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jocmr.2025.101980_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3663","article-title":"Accelerated ferumoxytol-enhanced 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) cardiovascular MRI: validation in pediatric congenital heart disease","volume":"30","author":"Zhou","year":"2017","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jocmr.2025.101980_bib69","article-title":"Ferumoxytol-enhanced 5D multiphase steady-state imaging using rotating Cartesian K-space with low-rank reconstruction for pediatric congenital heart disease","author":"Zhao","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib70","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/mrm.27898","article-title":"An automated approach to fully self-gated free-running cardiac and respiratory motion-resolved 5D whole-heart MRI","volume":"82","author":"Di Sopra","year":"2019","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mrm.28713","article-title":"Similarity-driven multi-dimensional binning algorithm (SIMBA) for free-running motion-suppressed whole-heart MRA","volume":"86","author":"Heerfordt","year":"2021","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib72","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mrm.22898","article-title":"Spiral phyllotaxis: the natural way to construct a 3D radial trajectory in MRI","volume":"66","author":"Piccini","year":"2011","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12968-022-00871-3","article-title":"Free-running cardiac and respiratory motion-resolved 5D whole-heart coronary cardiovascular magnetic resonance angiography in pediatric cardiac patients using ferumoxytol","volume":"24","author":"Roy","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib74","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1002\/jmri.26211","article-title":"Value of MRI in medicine: more than just another test?","volume":"49","author":"van Beek","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib75","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/jmri.25180","article-title":"Assessment of the precision and reproducibility of ventricular volume, function, and mass measurements with ferumoxytol-enhanced 4D flow MRI","volume":"44","author":"Hanneman","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib76","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1038\/s41598-017-04676-8","article-title":"Comprehensive multi-dimensional MRI for the simultaneous assessment of cardiopulmonary anatomy and physiology","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocmr.2025.101980_bib77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/CIRCIMAGING.111.966986","article-title":"Systemic-to-pulmonary collateral flow, as measured by cardiac magnetic resonance imaging, is associated with acute post-Fontan clinical outcomes","volume":"5","author":"Glatz","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib78","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10334-018-0702-z","article-title":"Evaluation of atrial septal defects with 4D flow MRI-multilevel and inter-reader reproducibility for quantification of shunt severity","volume":"32","author":"Chelu","year":"2019","journal-title":"Magma"},{"key":"10.1016\/j.jocmr.2025.101980_bib79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12968-023-00942-z","article-title":"4D flow cardiovascular magnetic resonance consensus statement: 2023 update","volume":"25","author":"Bissell","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12968-022-00886-w","article-title":"Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease","volume":"24","author":"Kollar","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib81","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-021-00789-2","article-title":"Moving beyond size: vorticity and energy loss are correlated with right ventricular dysfunction and exercise intolerance in repaired Tetralogy of Fallot","volume":"23","author":"Loke","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib82","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00247-018-4312-8","article-title":"4-D flow magnetic-resonance-imaging-derived energetic biomarkers are abnormal in children with repaired tetralogy of Fallot and associated with disease severity","volume":"49","author":"Robinson","year":"2019","journal-title":"Pedia Radio"},{"key":"10.1016\/j.jocmr.2025.101980_bib83","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jmri.25830","article-title":"Turbulent kinetic energy in the right ventricle: potential MR marker for risk stratification of adults with repaired Tetralogy of Fallot","volume":"47","author":"Fredriksson","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib84","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jtcvs.2014.11.085","article-title":"Ventricular kinetic energy may provide a novel noninvasive way to assess ventricular performance in patients with repaired tetralogy of Fallot","volume":"149","author":"Jeong","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jocmr.2025.101980_bib85","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1007\/s00330-021-07813-0","article-title":"Assessment of ventricular flow dynamics by 4D-flow MRI in patients following surgical repair of d-transposition of the great arteries","volume":"31","author":"Callaghan","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib86","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1007\/s00330-015-4186-1","article-title":"Assessment of intracardiac flow and vorticity in the right heart of patients after repair of tetralogy of Fallot by flow-sensitive 4D MRI","volume":"26","author":"Hirtler","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib87","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.21037\/qims-23-183","article-title":"Comparison of aortic blood flow rotational direction in healthy volunteers and patients with bicuspid aortic valves using volumetric velocity-sensitive cardiovascular magnetic resonance imaging","volume":"13","author":"Ebel","year":"2023","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.jocmr.2025.101980_bib88","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005486","article-title":"Turbulent kinetic energy assessed by multipoint 4-dimensional flow magnetic resonance imaging provides additional information relative to echocardiography for the determination of aortic stenosis severity","volume":"10","author":"Binter","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib89","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ehjci\/jey096","article-title":"Disproportionate intraventricular viscous energy loss in Fontan patients: analysis by 4D flow MRI","volume":"20","author":"Kamphuis","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib90","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1532-429X-14-84","article-title":"Evaluation of 3D blood flow patterns and wall shear stress in the normal and dilated thoracic aorta using flow-sensitive 4D CMR","volume":"14","author":"B\u00fcrk","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib91","article-title":"Comparison of echo-planar imaging and compressed sensing in the estimation of flow metrics from aortic 4D flow MR imaging: a healthy volunteer study","author":"Aono","year":"2024","journal-title":"Magn Reson Med Sci"},{"key":"10.1016\/j.jocmr.2025.101980_bib92","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.jbiomech.2015.07.039","article-title":"The effect of resolution on viscous dissipation measured with 4D flow MRI in patients with Fontan circulation: evaluation using computational fluid dynamics","volume":"48","author":"Cibis","year":"2015","journal-title":"J Biomech"},{"key":"10.1016\/j.jocmr.2025.101980_bib93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jmri.27804","article-title":"Traveling volunteers: a multi-vendor, multi-center study on reproducibility and comparability of 4D flow derived aortic hemodynamics in cardiovascular magnetic resonance","volume":"55","author":"Demir","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib94","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00247-021-05225-2","article-title":"High-resolution three\u2011dimensional contrast\u2011enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol","volume":"52","author":"Shahrouki","year":"2022","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib95","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210430","article-title":"Minimizing table time in patients with claustrophobia using focused ferumoxytol-enhanced MR angiography (f-FEMRA): a feasibility study","volume":"94","author":"Shahrouki","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib96","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jcmg.2020.01.006","article-title":"Coronary magnetic resonance angiography","volume":"13","author":"Hajhosseiny","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib97","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrm.27354","article-title":"Five-minute whole-heart coronary MRA with sub-millimeter isotropic resolution, 100% respiratory scan efficiency, and 3D-PROST reconstruction","volume":"81","author":"Bustin","year":"2019","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib98","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12968-020-00611-5","article-title":"3D whole-heart isotropic sub-millimeter resolution coronary magnetic resonance angiography with non-rigid motion-compensated PROST","volume":"22","author":"Bustin","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib99","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mrm.27853","article-title":"Comparison of gadolinium-enhanced and ferumoxytol-enhanced conventional and UTE-MRA for the depiction of the pulmonary vasculature","volume":"82","author":"Knobloch","year":"2019","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib100","doi-asserted-by":"crossref","first-page":"W366","DOI":"10.2214\/AJR.15.14534","article-title":"Vascular imaging with ferumoxytol as a contrast agent","volume":"205","author":"Hope","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jocmr.2025.101980_bib101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.crad.2018.02.021","article-title":"Ferumoxytol-enhanced MRI in the peripheral vasculature","volume":"74","author":"Lehrman","year":"2019","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib102","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2020190077","article-title":"Comparison of ferumoxytol-enhanced MR angiography and CT angiography for the detection of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: initial results","volume":"2","author":"Khan","year":"2020","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12968-019-0528-5","article-title":"High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion","volume":"21","author":"Shahrouki","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2016.12.147","article-title":"Ferumoxytol MRA for transcatheter aortic valve replacement planning with renal insufficiency","volume":"231","author":"Kallianos","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib105","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jvs.2019.08.240","article-title":"Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment","volume":"71","author":"Yoshida","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jocmr.2025.101980_bib106","article-title":"Gated thoracic magnetic resonance angiography at 3T: noncontrast versus blood pool contrast","author":"Zhu","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12968-019-0587-7","article-title":"Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis","volume":"21","author":"Tada","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jocmr.2025.101980_bib108","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jcmg.2018.08.028","article-title":"Cardiac magnetic resonance fingerprinting: technical overview and initial results","volume":"11","author":"Liu","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib109","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41551-018-0217-y","article-title":"Magnetic resonance multitasking for motion-resolved quantitative cardiovascular imaging","volume":"2","author":"Christodoulou","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jocmr.2025.101980_bib110","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/mrm.29968","article-title":"Non-electrocardiogram-gated, free-breathing, off-resonance reduced, high-resolution, whole-heart myocardial T(2) * mapping at 3 T within 5\u2009min","volume":"91","author":"Guan","year":"2024","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib111","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/mrm.29449","article-title":"Free-running 3D whole-heart T(1) and T(2) mapping and cine MRI using low-rank reconstruction with non-rigid cardiac motion correction","volume":"89","author":"Phair","year":"2023","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib112","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/jmri.21147","article-title":"Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients","volume":"26","author":"Dewey","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jmri.24330","article-title":"Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases","volume":"40","author":"Bashir","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib114","article-title":"Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy: a randomized controlled trial","volume":"5","author":"Awomolo","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jocmr.2025.101980_bib115","article-title":"Neonatal outcomes from a randomized controlled trial of maternal treatment of iron deficiency anemia with intravenous ferumoxytol vs oral ferrous sulfate","volume":"5","author":"Awomolo","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jocmr.2025.101980_bib116","unstructured":"National Kidney Foundation. Kidney Disease: The Basics. \u3008https:\/\/www.kidney.org\/news\/newsroom\/fsindex\u3009. Accessed July 27, 2024. Accessed July 7."},{"key":"10.1016\/j.jocmr.2025.101980_bib117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00330-017-4934-5","article-title":"Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients","volume":"28","author":"Stoumpos","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib118","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/TP.0b013e318295464c","article-title":"Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent","volume":"96","author":"Bashir","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jocmr.2025.101980_bib119","article-title":"MR angiography of renal transplant vasculature with ferumoxytol: comparison of high-resolution steady-state and first-pass acquisitions","author":"Corwin","year":"2015","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jmri.25421","article-title":"Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis","volume":"45","author":"Fananapazir","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib121","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1540-8159.2005.50024.x","article-title":"Current clinical issues for MRI scanning of pacemaker and defibrillator patients","volume":"28","author":"Kalin","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib122","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCIMAGING.111.965764","article-title":"Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators","volume":"4","author":"Sasaki","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib123","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2214\/AJR.11.7364","article-title":"Metal-induced artifacts in MRI","volume":"197","author":"Hargreaves","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jocmr.2025.101980_bib124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/radiol.13130942","article-title":"Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices","volume":"270","author":"Rashid","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib125","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mrm.26223","article-title":"Myocardial T1 mapping for patients with implanted cardiac devices using wideband inversion recovery spoiled gradient echo readout","volume":"77","author":"Shao","year":"2017","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jocmr.2025.101980_bib126","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/ehjci\/jex243","article-title":"Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality","volume":"19","author":"Hilbert","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib127","first-page":"237","article-title":"Blood flow effects in magnetic resonance imaging","author":"Axel","year":"1986","journal-title":"Magn Reson Annu"},{"key":"10.1016\/j.jocmr.2025.101980_bib128","unstructured":"Nguyen K.L., Yoshida T., Hu P., Finn J.P. Ferumoxytol-enhanced cardiac cine MRI in patients with implanted cardiac devices. Paper\/Poster presented at: 25th Annual ISMRM Scientific Sessions; April 22\u201327, 2017, 2017; Honolulu, HI, USA."},{"key":"10.1016\/j.jocmr.2025.101980_bib129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.iac.2014.04.013","article-title":"Hypersensitivity from intravenous iron products","volume":"34","author":"Bircher","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jocmr.2025.101980_bib130","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ajh.27220","article-title":"Expert consensus guidelines: intravenous iron uses, formulations, administration, and management of reactions","volume":"99","author":"Van Doren","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jocmr.2025.101980_bib131","doi-asserted-by":"crossref","DOI":"10.1007\/s00247-024-05970-0","article-title":"A case of severe anaphylactic reaction after administration of diagnostic-dose ferumoxytol in a pediatric patient","author":"Ekladious","year":"2024","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jocmr.2025.101980_bib132","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.4488","article-title":"Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions","volume":"5","author":"Arastu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jocmr.2025.101980_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24132","article-title":"Premedication with IV steroids effectively prevented anaphylactic reactions following ferumoxytol given as IV push in hematology and oncology patients","volume":"90","author":"Braaten","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jocmr.2025.101980_bib134","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2019190477","article-title":"Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI","volume":"293","author":"Nguyen","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jocmr.2025.101980_bib135","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1007\/s00247-023-05778-4","article-title":"Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study","volume":"53","author":"Dasi","year":"2023","journal-title":"Pedia Radio"},{"key":"10.1016\/j.jocmr.2025.101980_bib136","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.anai.2018.11.003","article-title":"An ounce of caution: superparamagnetic iron oxide nanoparticle based magnetic resonance imaging contrast-associated anaphylaxis","volume":"122","author":"Heckman","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jocmr.2025.101980_bib137","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/jmri.28457","article-title":"Comparison of three ultrasmall, superparamagnetic iron oxide nanoparticles for MRI at 3.0\u2009T","volume":"57","author":"Colbert","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jocmr.2025.101980_bib138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.matlet.2016.02.006","article-title":"An efficient synthesis of ferumoxytol induced by alternating-current magnetic field","volume":"170","author":"Chen","year":"2016","journal-title":"Mater Lett"},{"key":"10.1016\/j.jocmr.2025.101980_bib139","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1039\/C8NR00736E","article-title":"Ferumoxytol of ultrahigh magnetization produced by hydrocooling and magnetically internal heating co-precipitation","volume":"10","author":"Chen","year":"2018","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.jocmr.2025.101980_bib140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/jmri.29537","article-title":"Exploring prolonged efficacy of ferumoxytol\u2010enhanced whole\u2010body angiography: a preliminary study in healthy male subjects","volume":"61","author":"Si","year":"2025","journal-title":"J Magn Reson Imaging"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664725001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664725001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:59:10Z","timestamp":1778590750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664725001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"alternative-id":["S1097664725001425"],"URL":"https:\/\/doi.org\/10.1016\/j.jocmr.2025.101980","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferumoxytol-enhanced cardiovascular magnetic resonance imaging: applications and technical advances","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocmr.2025.101980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Society for Cardiovascular Magnetic Resonance.","name":"copyright","label":"Copyright"}],"article-number":"101980"}}